Neurointerventional medicine, also known as 'interventional neuroradiology', refers to the diagnosis and treatment of central nervous system, head and neck, spinal diseases, etc., through the combination of percutaneous puncture catheter technology and radiological imaging. Compared with surgical operations, neurointerventional medicine reduces risks in multiple dimensions. For example, treatment can be completed without exposing the lesion through surgery, which not only results in less damage and faster recovery but also reduces the risks of anesthesia complications, infections, etc. Neurointerventional devices refer to a general term for a series of medical consumables used for diagnosing and treating cerebrovascular diseases around neurointerventional procedures. With continuous investment in national healthcare, improved residents' payment capabilities, and the intensification of the aging population trend, the market scale of medical consumables for neurovascular disease interventional treatment in China has been growing rapidly, with broad market prospects in the future. For this reason, based on research on this market, Frost & Sullivan (Frost & Sullivan) released an independent research report titled 'The Neurointerventional Medical Device Market'.
If you have further research needs on the neurointerventional medical device market, please contact us:
Mr. Ma, Frost & Sullivan
Tel: (+86) 159-2139-6033
E-mail: fred.mao@frostchina.com
